Tuesday, September 22, 2020

Sun Pharma's subsidiary launches Ilumya in Japan

Ilumya Subcutaneous Injection 100 mg Syringe (tildrakizumab) will be used for treatment of Plaque Psoriasis.

from India Infoline News Service https://ift.tt/3j8FLxH
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)